Perspective Therapeutics, Inc. (CATX)
0.8424
+0.02
(+2.08%)
USD |
NYAM |
Nov 12, 16:00
0.867
+0.02
(+2.92%)
After-Hours: 20:00
Perspective Therapeutics Free Cash Flow (Quarterly) : -35.91M for Sept. 30, 2026
Free Cash Flow (Quarterly) Chart
Historical Free Cash Flow (Quarterly) Data
| Date | Value |
|---|---|
| September 30, 2026 | -35.91M |
| June 30, 2026 | -34.87M |
| March 31, 2026 | -38.33M |
| December 31, 2025 | -29.87M |
| September 30, 2025 | -18.32M |
| June 30, 2025 | -21.02M |
| March 31, 2025 | -26.25M |
| December 31, 2024 | -41.27M |
| September 30, 2024 | -26.37M |
| June 30, 2024 | -9.917M |
| March 31, 2024 | 4.776M |
| September 30, 2023 | -10.34M |
| June 30, 2023 | -8.645M |
| March 31, 2023 | -9.924M |
| June 30, 2022 | -3.014M |
| March 31, 2022 | -1.448M |
| December 31, 2021 | -1.394M |
| September 30, 2021 | -2.138M |
| June 30, 2021 | -1.256M |
| March 31, 2021 | -0.721M |
| December 31, 2020 | -0.82M |
| September 30, 2020 | -0.451M |
| June 30, 2020 | -0.887M |
| March 31, 2020 | -0.906M |
| December 31, 2019 | -1.384M |
| Date | Value |
|---|---|
| September 30, 2019 | -0.751M |
| June 30, 2019 | -1.076M |
| March 31, 2019 | -1.466M |
| December 31, 2018 | -1.225M |
| September 30, 2018 | -1.726M |
| June 30, 2018 | -1.572M |
| March 31, 2018 | -1.161M |
| December 31, 2017 | -1.619M |
| September 30, 2017 | -1.715M |
| June 30, 2017 | -1.442M |
| March 31, 2017 | -1.539M |
| December 31, 2016 | -1.753M |
| September 30, 2016 | -1.651M |
| June 30, 2016 | -1.438M |
| March 31, 2016 | -0.9671M |
| December 31, 2015 | -0.8417M |
| September 30, 2015 | -1.129M |
| June 30, 2015 | -0.6887M |
| March 31, 2015 | -1.176M |
| December 31, 2014 | -0.6556M |
| September 30, 2014 | -1.153M |
| June 30, 2014 | -1.004M |
| March 31, 2014 | -0.5067M |
| December 31, 2013 | -0.8574M |
| September 30, 2013 | -0.8966M |
Free Cash Flow Definition
Free Cash Flow is the cash a company has left after paying for its day-to-day operations and investing in its physical assets, such as buildings, equipment and technology. The company can use that cash however it chooses: paying dividends, buying back shares, paying down debt, making acquisitions or keeping it for future growth.
Free Cash Flow (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Free Cash Flow (Quarterly) Benchmarks
| Anika Therapeutics, Inc. | 6.716M |
| MiMedx Group, Inc. | 3.598M |
| ABVC BioPharma, Inc. | -0.4389M |
| Enovis Corp. | 34.99M |
| Edwards Lifesciences Corp. | 506.70M |